Investigating how FOXM1 contributes to eosinophilic esophagitis

The Role of FOXM1 in Eosinophilic Esophagitis Pathogenesis

NIH-funded research Children's Hosp of Philadelphia · NIH-10724896

This study is looking at how a protein called FOXM1 might cause problems in the esophagus for people with eosinophilic esophagitis (EoE), which makes it hard to swallow, and aims to find new ways to help improve treatments for this condition.

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionChildren's Hosp of Philadelphia NIH-funded
Lab location1 site (Philadelphia, United States)
Project IDNIH-10724896 on NIH RePORTER

What this research studies

This research focuses on eosinophilic esophagitis (EoE), a chronic allergic condition affecting the esophagus, leading to symptoms like difficulty swallowing and food impaction. The study aims to understand the role of a protein called FOXM1 in disrupting the normal function of esophageal cells, which may contribute to inflammation and other complications in EoE. Using advanced cell culture techniques, researchers will explore how FOXM1 affects the behavior of esophageal cells when exposed to specific inflammatory signals. The ultimate goal is to identify potential therapeutic targets that could improve treatment options for patients suffering from this condition.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with eosinophilic esophagitis who experience symptoms such as dysphagia or food impaction.

Not a fit: Patients without eosinophilic esophagitis or those with other unrelated gastrointestinal disorders may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that alleviate symptoms and improve the quality of life for patients with eosinophilic esophagitis.

How similar studies have performed: Previous research has shown promising results in understanding the role of inflammatory pathways in eosinophilic esophagitis, suggesting that this approach could yield valuable insights.

Where this research is happening

Philadelphia, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.